Quest Diagnostics
152.81
-0.46 (-0.30%)
At close: Jan 14, 2025, 3:59 PM
undefined%
Bid 149.13
Market Cap 17.06B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 7.44
PE Ratio (ttm) 20.54
Forward PE n/a
Analyst Hold
Ask 171
Volume 456,833
Avg. Volume (20D) 840,688
Open 153.05
Previous Close 153.27
Day's Range 150.47 - 153.12
52-Week Range 123.04 - 165.32
Beta undefined

About DGX

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPat...

Sector Healthcare
IPO Date Dec 17, 1996
Employees 50,000
Stock Exchange NYSE
Ticker Symbol DGX

Analyst Forecast

According to 13 analyst ratings, the average rating for DGX stock is "Hold." The 12-month stock price forecast is $172, which is an increase of 12.56% from the latest price.

Buy 53.85%
Hold 46.15%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Quest Diagnostics is scheduled to release its earnings on Jan 30, 2025, before market opens.
Analysts project revenue of $2.58B, reflecting a 12.76% YoY growth and earnings per share of 2.19, making a 1.86% increase YoY.
2 months ago · Source
+6.85%
Quest Diagnostics shares are trading higher after ... Unlock content with Pro Subscription
5 months ago · Source
-4.34%
Quest Diagnostics shares are trading lower. The company reported Q2 financial results.